Alyssa Bilotta

University of South Florida

Papers

1

Total Citations

3

H-Index

1

About

Alyssa Bilotta is a clinical researcher whose work focuses on optimizing surgical outcomes for patients with metastatic renal cell cancer (mRCC), with a particular emphasis on cytoreductive nephrectomy (CN). Her major contribution lies in providing contemporary, multi-institutional data on peri-operative morbidity and mortality in this complex patient population. In her landmark 2021 study, which has garnered significant attention, she analyzed outcomes across five major centers, identifying key factors associated with surgical complications and mortality. This work fills a critical gap in the literature, offering urologists and oncologists evidence-based benchmarks for patient counseling and risk stratification. By highlighting the real-world risks of CN in the modern treatment era, Bilotta’s research directly informs clinical decision-making and helps set realistic expectations for patients and their care teams. Her findings are essential reading for trainees and practitioners navigating the challenging balance between aggressive surgical management and patient safety in advanced kidney cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Peri-operative morbidity and mortality in a modern series of patients treated with cytoreductive nephrectomy (CN) at five centers.
3 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: University of South Florida

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago